Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?
Pol Arch Med Wewn
2009; 119: 469–77.
Von Korff, M, Saunders, K, Thomas Ray, G, Boudreau, D, Campbell, C, Merrill, J, et al.
De facto long-term opioid therapy for noncancer pain. Clin J Pain
2008; 24: 521–7.
Scherrer, JF, Salas, J, Copeland, LA, Stock, EM, Ahmedani, BK, Sullivan, MD, et al.
Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Fam Med
2016; 14: 54–62.
Vanderlip, ER, Sullivan, MD, Edlund, MJ, Martin, BC, Fortney, J, Austen, M, et al.
National study of discontinuation of long-term opioid therapy among veterans. Pain
2014; 155: 2673–94.
Martin, BC, Fan, MY, Edlund, MJ, Devries, A, Brennan-Braden, J, Sullivan, MD.
Long-term chronic opioid therapy discontinuation rtes from the TROUP study. J Gen Intern Med
2011; 26: 1450–7.
Scherrer, JF, Salas, J, Sullivan, MD, Schneider, FD, Bucholz, KK, Burroughs, T, et al.
The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med
2016; 91: 110–6.
Scherrer, JF, Svrakic, DM, Freedland, KE, Chrusciel, T, Balasubramanian, S, Bucholz, KK, et al.
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med
2014; 29: 491–9.
Why does depression promote long-term opioid use?
2016; 157: 2395–6.
Kroenke, K, Bair, MJ, Damush, TM, Wu, J, Hoke, S, Sutherland, J, et al.
Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA
2009; 301: 2099–110.
Kroenke, K, Wu, J, Bair, MJ, Krebs, EE, Damush, TM, Tu, W.
Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain
2011; 12: 964–73.
Vowles, KE, Witkiewitz, K, Levell, J, Sowden, G, Ashworth, J.
Are reductions in pain intensity and pain-related distress necessary? An analysis of within-treatment change trajectories in relation to improved functioning following interdisciplinary acceptance and commitment therapy for adults with chronic pain. J Consult Clin Psychol
2017; 85: 87–98.
Ho, SC, Chong, HY, Chaiyakunapruk, N, Tangiisuran, B, Jacob, SA.
Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord
2016; 193: 1–10.
Akerblad, AC, Bengtsson, F, von Knorring, L, Ekselius, L.
Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study. Int Clin Psychopharmacol
2006; 21: 117–24.
Kroenke, K, Spitzer, RL, Williams, JB.
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med
2001; 16: 606–13.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–9). WHO, 1978.
Frayne, SM, Miller, DR, Sharkansky, EJ, Jackson, VW, Wang, F, Halanych, JH, et al.
Using administrative data to identify mental illness: what approach is best?
Am J Med Qual
2010; 25: 42–50.
Solberg, LI, Engebretson, KI, Sperl-Hillen, JM, Hroscikoski, MC, O'Connor, PG.
Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease and depression. Am J Med Qual
2006; 21: 238–45.
National Committee for Quality Assurance. The State of Health Care Quality. National Committee for Quality Assurance, 2013.
Hess, LM, Raebel, MA, Conner, DA, Malone, DC.
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother
2006; 40: 1280–8.
Cramer, JA, Roy, A, Burrell, A, Fairchild, CJ, Fuldeore, MJ, Ollendorf, DA, et al.
Medication compliance and persistence: terminology and definitions. Value Health
2008; 11: 44–7.
Quinn, PD, Hur, K, Chang, Z, Krebs, EE, Bair, MJ, Scott, EL, et al.
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain
2017; 158: 140–8.
Physical Consequences of Depression. Wrightson Biomedical Publishing, 2001.
Seal, KH, Shi, Y, Cohen, G, Cohen, BE, Maguen, S, Krebs, EE, et al.
Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA
2012; 307: 940–7.
Correa, D, Farney, RJ, Chung, F, Prasad, A, Lam, D, Wong, J.
Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations. Anesth Analg
2015; 120: 1273–85.
O'Rourke, TK Jr, Wosnitzer, MS.
Opioid-induced androgen deficiency (OPIAD): diagnosis, management, and literature review. Curr Urol Rep
2016; 17: 76.
Dobscha, SK, Morasco, BJ, Kovas, AE, Peters, DM, Hart, K, McFarland, BH.
Short-term variability in outpatient pain intensity scores in a national sample of older veterans with chronic pain. Pain Med
2015; 16: 855–65.
Cole, SR, Hernan, MA.
Constructing inverse probability weights for marginal structural models. Am J Epidemiol
2008; 168: 656–64.
Curtis, LH, Hammill, BG, Eisenstein, EL, Kramer, JM, Anstrom, KJ.
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care
2007; 45 (10 Supl 2): S103–7.
Harder, VS, Stuart, EA, Anthony, JC.
Propsensity score techinques and the assessment of measure covariate balance to test causal associations in psychological research. Psychol Methods
2010; 15: 234–49.
Kilpatrick, RD, Gilbertson, D, Brookhart, MA, Polley, E, Rothman, KJ, Bradbury, BD.
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rate treatment decisions. Pharmacoepidemiol Drug Saf
2013; 22: 111–21.
Rosenbaum, PR, Rubin, DB.
The central role of the prospensity score in observational studies for causal effects. Biometrika
1983; 70; 41–55.
Xu, S, Ross, C, Raebel, MA, Shetterly, S, Blanchette, C, Smith, D.
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health
2010; 13: 273–7.
Austin, P, Stuart, E.
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med
2015; 34: 3661–79.
Sturmer, T, Wyss, R, Glynn, RJ, Brookhart, MA.
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med
2014; 275: 570–80.
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med
2009; 28: 3083–107.
Howe, CQ, Sullivan, MD.
The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. Gen Hosp Psychiatry
2014; 36: 99–104.
Berna, C, Kulich, RJ, Rathmell, JP.
Tapering long term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc
2015; 90: 828–42.
Bitton, A, Choudhry, NK, Matlin, OS, Swanton, K, Shrank, WH.
The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med
2013; 126: 357.e7–e27.
Scherrer, JF, Salas, J, Copeland, LA, Stock, EM, Schneider, FD, Sullivan, M, et al.
Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain
2016; 17: 473–82.
Skljarevski, V, Desaiah, D, Liu-Seifert, H, Zhang, Q, Chappell, AS, Detke, MJ, et al.
Efficacy and safety of duloxetine in patients with chronic low back pain. Spine
2010; 35: E578–E85.
Atkinson, JH, Patel, SM, Meyer, JM, Slater, MA, Zisook, S, Capparelli, E.
Is there a therapeutic window with some antidepressants for analgesic response?
Curr Pain Headache Rep
2009; 13: 93–9.